{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:19:59Z","timestamp":1786990799651,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijregi.2026.100869","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:08:06Z","timestamp":1771952886000},"page":"100869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Anti-tuberculosis drug-induced hepatotoxicity among patients undergoing tuberculosis treatment at the Antituberculosis Center of Brazzaville, Republic of Congo"],"prefix":"10.1016","volume":"19","author":[{"given":"Emmanuel Fonfon","family":"Ebata-Mboussa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrel Ornelle Elion","family":"Assiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanikany","family":"Moyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5838-6106","authenticated-orcid":false,"given":"Freisnel Hermeland","family":"Mouzinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon Tchuandom","family":"Bonsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erudit Beny","family":"Elenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck Hardain","family":"Okemba-Okombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faust Ren\u00e9 Okamba","family":"Ondzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2026.100869_bib0001","article-title":"Population-wide active case finding as a strategy to end TB","volume":"46","author":"Nguyen","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ijregi.2026.100869_bib0002","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijtb.2019.11.005","article-title":"Adverse drug reactions in tuberculosis and management","volume":"66","author":"Prasad","year":"2019","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.ijregi.2026.100869_bib0003","article-title":"Tuberculosis treatment outcomes and their related factors in patients with tuberculosis treated at the Antituberculosis Center of Brazzaville, Republic of Congo","volume":"15","author":"Ngouama","year":"2025","journal-title":"IJID Reg"},{"key":"10.1016\/j.ijregi.2026.100869_bib0004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijmyco.2015.10.002","article-title":"Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study","volume":"5","author":"Abera","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.ijregi.2026.100869_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021836","article-title":"Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China","volume":"6","author":"Shang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100869_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8266878","article-title":"Incidence and temporal trend of antituberculosis drug-induced liver injury: a systematic review and meta-analysis","volume":"2022","author":"Wang","year":"2022","journal-title":"J Trop Med"},{"key":"10.1016\/j.ijregi.2026.100869_bib0007","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/14740338.2024.2399074","article-title":"Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis","volume":"23","author":"Lewis","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ijregi.2026.100869_bib0008","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12879-017-2330-z","article-title":"Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK","volume":"17","author":"Abbara","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100869_bib0009","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-008-9085-y","article-title":"A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases","volume":"2","author":"Makhlouf","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijregi.2026.100869_bib0010","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/liv.14896","article-title":"Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): large cohort study involving 4652 Chinese adult tuberculosis patients","volume":"41","author":"Jiang","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.ijregi.2026.100869_bib0011","first-page":"961","article-title":"Inflammatory status hepatic enzymes and serum creatinine in HIV-, HIV+ and HIV-TB co-infected adult Central Africans","volume":"5","author":"Mokondjimobe","year":"2012","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.ijregi.2026.100869_bib0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12941-025-00786-8","article-title":"Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of Congo","volume":"24","author":"Ngouama","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijregi.2026.100869_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2025-019877","article-title":"Eight-year tuberculosis epidemic trends in the Republic of Congo, a high TB burden country: progress and gaps towards end-TB targets","volume":"10","author":"Mouzinga","year":"2025","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijregi.2026.100869_bib0014","first-page":"23","article-title":"Strengthening the national reference laboratory in the Republic of Congo: an investment imperative for tuberculosis diagnostics","volume":"11","author":"Elion Assiana","year":"2026","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100869_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15855-3","article-title":"Antitubercular drug induced liver injury among tuberculosis patients in central Ethiopia","volume":"15","author":"Petros","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijregi.2026.100869_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13104-019-4872-1","article-title":"Drug-induced hepatotoxicity among TB\/HIV co-infected patients in a referral hospital, Ethiopia","volume":"13","author":"Zeleke","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijregi.2026.100869_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijmyco.2015.10.001","article-title":"Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria","volume":"5","author":"Isa","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.ijregi.2026.100869_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250368","article-title":"Prevalence of elevated liver transaminases and their relationship with alcohol use in people living with HIV on anti-retroviral therapy in Uganda","volume":"16","author":"Freiman","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100869_bib0019","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12879-023-08085-3","article-title":"Prevalence and factors associated with reported adverse-events among patients on multi-drug-resistant tuberculosis treatment in two referral hospitals in Uganda","volume":"23","author":"Ategyeka","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100869_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijregi.2026.100869_bib0021","article-title":"Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijregi.2026.100869_bib0022","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ijregi.2026.100869_bib0023","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12664-024-01674-3","article-title":"Drug-induced liver injury due to first-line antituberculosis medications in India: a major hindrance to achieve the goal of tuberculosis elimination","volume":"44","author":"Gopalakrishna","year":"2025","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.ijregi.2026.100869_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2150131916642431","article-title":"Prevalence of hepatotoxicity from antituberculosis therapy: a five-year experience from South India","volume":"7","author":"Saha","year":"2016","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.ijregi.2026.100869_bib0025","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1017\/S0950268820002861","article-title":"The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies","volume":"148","author":"Zheng","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijregi.2026.100869_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/03000605251348228","article-title":"Liver functions and medication adherence in tuberculosis patients after 6 months of antituberculosis treatment in Indonesia","volume":"53","author":"Perwitasari","year":"2025","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijregi.2026.100869_bib0027","article-title":"Drug-induced liver injury from anti-tuberculosis treatment: A retrospective cohort study","volume":"26","author":"Zhao","year":"2020","journal-title":"Med Sci Monit"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:45:38Z","timestamp":1782751538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707626000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S2772707626000330"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100869","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-tuberculosis drug-induced hepatotoxicity among patients undergoing tuberculosis treatment at the Antituberculosis Center of Brazzaville, Republic of Congo","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100869"}}